{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:34:51Z","timestamp":1778916891233,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grant-in-Aid for Young Scientists","award":["21K15970"],"award-info":[{"award-number":["21K15970"]}]},{"name":"Grant-in-Aid for Scientific Researc","award":["20K08382"],"award-info":[{"award-number":["20K08382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12072-023-10581-2","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:02:14Z","timestamp":1693828934000},"page":"1378-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis"],"prefix":"10.1007","volume":"17","author":[{"given":"Yoshiaki","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-0952","authenticated-orcid":false,"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Zaitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"issue":"7","key":"10581_CR1","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, Type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679-1694.e3. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.055","journal-title":"Gastroenterology"},{"issue":"3","key":"10581_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JYL Chiang","year":"2013","unstructured":"Chiang JYL. Bile acid metabolism and signaling. Compr Physiol. 2013;3(3):1191\u20131212. https:\/\/doi.org\/10.1002\/cphy.c120023","journal-title":"Compr Physiol"},{"issue":"7456","key":"10581_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97\u2013101. https:\/\/doi.org\/10.1038\/nature12347","journal-title":"Nature"},{"issue":"6391","key":"10581_CR4","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360(6391):5931. https:\/\/doi.org\/10.1126\/science.aan5931","journal-title":"Science"},{"issue":"10","key":"10581_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/apt.16602","volume":"54","author":"B Simbrunner","year":"2021","unstructured":"Simbrunner B, Trauner M, Reiberger T. Review article: therapeutic aspects of bile acid signalling in the gut-liver axis. Aliment Pharmacol Ther. 2021;54(10):1243\u20131262. https:\/\/doi.org\/10.1111\/apt.16602","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10581_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u2013128. https:\/\/doi.org\/10.1038\/nrgastro.2017.119","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10581_CR7","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/ajg.2011.285","volume":"106","author":"BS Wong","year":"2011","unstructured":"Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011;106(12):2154\u20132164. https:\/\/doi.org\/10.1038\/ajg.2011.285","journal-title":"Am J Gastroenterol"},{"key":"10581_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","volume":"16","author":"N Kishida","year":"2016","unstructured":"Kishida N, Matsuda S, Itano O, Shinoda M, Kitago M, Yagi H, et al. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. BMC Gastroenterol. 2016;16:61. https:\/\/doi.org\/10.1186\/s12876-016-0477-5","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"10581_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.dld.2021.02.013","volume":"53","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Honda T, Yokoyama S, Ma L, Kato A, Ito T, et al. Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine. Dig Liver Dis. 2021;53(11):1443\u20131450. https:\/\/doi.org\/10.1016\/j.dld.2021.02.013","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10581_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u2013857. https:\/\/doi.org\/10.1038\/s41587-019-0209-9","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10581_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869","journal-title":"Nat Methods"},{"key":"10581_CR12","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590\u2013D596. https:\/\/doi.org\/10.1093\/nar\/gks1219","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10581_CR13","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1021\/acsomega.1c00403","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano T, Taki K, Kitamori K, Naito H, Nakajima T, Tsuchihashi H, et al. One-pot extraction and quantification method for bile acids in the rat liver by capillary liquid chromatography tandem mass spectrometry. ACS Omega. 2021;6(12):8588\u20138597. https:\/\/doi.org\/10.1021\/acsomega.1c00403","journal-title":"ACS Omega"},{"issue":"3","key":"10581_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41596-019-0264-1","volume":"15","author":"J Chong","year":"2020","unstructured":"Chong J, Liu P, Zhou G, Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15(3):799\u2013821. https:\/\/doi.org\/10.1038\/s41596-019-0264-1","journal-title":"Nat Protoc"},{"issue":"6","key":"10581_CR15","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol"},{"key":"10581_CR16","doi-asserted-by":"publisher","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","volume":"116","author":"N Nimer","year":"2021","unstructured":"Nimer N, Choucair I, Wang Z, Nemet I, Li L, Gukasyan J, et al. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression. Metabolism. 2021;116:154457. https:\/\/doi.org\/10.1016\/j.metabol.2020.154457","journal-title":"Metabolism"},{"issue":"1","key":"10581_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/liv.15041","volume":"42","author":"T Inoue","year":"2022","unstructured":"Inoue T, Funatsu Y, Ohnishi M, Isogawa M, Kawashima K, Tanaka M, et al. Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection. Liver Int. 2022;42(1):124\u2013134. https:\/\/doi.org\/10.1111\/liv.15041","journal-title":"Liver Int"},{"issue":"5","key":"10581_CR18","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.3892\/etm.2019.8011","volume":"18","author":"N Liu","year":"2019","unstructured":"Liu N, Feng J, Lv Y, Liu Q, Deng J, Xia Y, et al. Role of bile acids in the diagnosis and progression of liver cirrhosis: a prospective observational study. Exp Ther Med. 2019;18(5):4058\u20134066. https:\/\/doi.org\/10.3892\/etm.2019.8011","journal-title":"Exp Ther Med"},{"issue":"2","key":"10581_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/hep.29561","volume":"67","author":"P Luo","year":"2018","unstructured":"Luo P, Yin P, Hua R, Tan Y, Li Z, Qiu G, et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018;67(2):662\u2013675. https:\/\/doi.org\/10.1002\/hep.29561","journal-title":"Hepatology"},{"key":"10581_CR20","doi-asserted-by":"publisher","first-page":"778258","DOI":"10.3389\/fonc.2021.778258","volume":"11","author":"J Fu","year":"2021","unstructured":"Fu J, Yu M, Xu W, Yu S. Research progress of bile acids in cancer. Front Oncol. 2021;11:778258. https:\/\/doi.org\/10.3389\/fonc.2021.778258","journal-title":"Front Oncol"},{"issue":"2","key":"10581_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","volume":"77","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang Z, Bao R, Guo X, Gu Y, Yang W, et al. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol. 2022;77(2):453\u2013466. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.030","journal-title":"J Hepatol"},{"issue":"2","key":"10581_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.13457","volume":"43","author":"H Graffner","year":"2016","unstructured":"Graffner H, Gillberg PG, Rikner L, Marschall HU. The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. Aliment Pharmacol Ther. 2016;43(2):303\u2013310. https:\/\/doi.org\/10.1111\/apt.13457","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10581_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/jgh.15800","volume":"37","author":"A Nakajima","year":"2022","unstructured":"Nakajima A, Ishizaki S, Matsuda K, Kurosu S, Taniguchi S, Gillberg PG, et al. Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation. J Gastroenterol Hepatol. 2022;37(5):883\u2013890. https:\/\/doi.org\/10.1111\/jgh.15800","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10581_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12072-020-10107-0","volume":"15","author":"R Yamauchi","year":"2021","unstructured":"Yamauchi R, Takedatsu H, Yokoyama K, Yamauchi E, Kawashima M, Nagata T, et al. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice. Hepatol Int. 2021;15(2):392\u2013404. https:\/\/doi.org\/10.1007\/s12072-020-10107-0","journal-title":"Hepatol Int"},{"issue":"5","key":"10581_CR25","doi-asserted-by":"publisher","first-page":"e00070","DOI":"10.1128\/mSystems.00070-16","volume":"1","author":"L Zhang","year":"2016","unstructured":"Zhang L, Xie C, Nichols RG, Chan SHJ, Jiang C, Hao R, et al. Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism. mSystems. 2016;1(5):e00070-e116. https:\/\/doi.org\/10.1128\/mSystems.00070-16","journal-title":"mSystems."},{"key":"10581_CR26","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun. 2013;4:2384. https:\/\/doi.org\/10.1038\/ncomms3384","journal-title":"Nat Commun"},{"issue":"1","key":"10581_CR27","doi-asserted-by":"publisher","first-page":"G91","DOI":"10.1152\/ajpgi.00027.2015","volume":"311","author":"L Sun","year":"2016","unstructured":"Sun L, Beggs K, Borude P, Edwards G, Bhushan B, Walesky C, et al. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling. Am J Physiol Gastrointest Liver Physiol. 2016;311(1):G91\u2013G104. https:\/\/doi.org\/10.1152\/ajpgi.00027.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10581_CR28","doi-asserted-by":"publisher","first-page":"711448","DOI":"10.3389\/fonc.2021.711448","volume":"11","author":"Y Gong","year":"2021","unstructured":"Gong Y, Li K, Qin Y, Zeng K, Liu J, Huang S, et al. Norcholic acid promotes tumor progression and immune escape by regulating farnesoid X receptor in hepatocellular carcinoma. Front Oncol. 2021;11:711448. https:\/\/doi.org\/10.3389\/fonc.2021.711448","journal-title":"Front Oncol"},{"issue":"4","key":"10581_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/19490976.2020.1743492","volume":"11","author":"V Singh","year":"2020","unstructured":"Singh V, Yeoh BS, Abokor AA, Golonka RM, Tian Y, Patterson AD, et al. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota. Gut Microbes. 2020;11(4):1077\u20131091. https:\/\/doi.org\/10.1080\/19490976.2020.1743492","journal-title":"Gut Microbes"},{"issue":"9","key":"10581_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"LX Yu","year":"2017","unstructured":"Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14(9):527\u2013539. https:\/\/doi.org\/10.1038\/nrgastro.2017.72","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10581-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10581-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10581-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:38:26Z","timestamp":1700527106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10581-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10581"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10581-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2920999\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yoshiaki Sugiyama, Kenta Yamamoto, Takashi Honda, Asuka Kato, Hisanori Muto, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Tomomi Asano, Atsushi Enomoto, Kei Zaitsu, Masatoshi Ishigami, Mitsuhiro Fujishiro, Hiroki Kawashima have no relevant financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Animal Care and Research and Development Committees of the Division of Experimental Animals at Nagoya University approved all experiments. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}